A GWAS-identified susceptibility locus on chromosome 11q13.3 and its putative molecular target for prediction of postoperative prognosis of human renal cell carcinoma

Oncology Letters

Volumn 6, Issue 2, 2013, Pages 421-426

  Su, Tong ^a   Han, Yifang ^a   Yu, Yongwei ^b   Tan, Xiaojie ^a   Li, Xiaopan ^a   Hou, Jianguo ^b   Du, Yan ^a   Shen, Jian ^b   Wang, Guoping ^a   Ma, Liye ^b   Jiang, Shuang ^b   Zhang, Hongwei ^a   Cao, Guangwen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cyclin D1; Prognosis; Renal cell carcinoma; Risk; Single nucleotide polymorphism

Indexed keywords

CYCLIN D1; HYPOXIA INDUCIBLE FACTOR 2ALPHA;

ADULT; AGED; ARTICLE; CANCER RISK; CHROMOSOME; CHROMOSOME 11Q13.3; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING;

EID: 84879492901     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1422     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin61: 69-90, 2011.
2. Chow WH, Dong LM and Devesa SS: Epidemiology and risk factors for kidney cancer. Nat Rev Urol7: 245-257, 2010.
3. Southard EB, Roff A, Fortugno T, et al: Lead, calcium uptake, and related genetic variants in association with renal cell carcinoma risk in a cohort of male Finnish smokers. Cancer Epidemiol Biomarkers Prev21: 191-201, 2012.
4. Wang G, Hou J, Ma L, et al: Risk factor for clear cell renal cell carcinoma in Chinese population: a case-control study. Cancer Epidemiol36: 177-182, 2012.
5. Moore LE, Brennan P, Karami S, et al: Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study. Carcinogenesis28: 1960-1964, 2007.
6. Moore LE, Boffetta P, Karami S, et al: Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants. Cancer Res70: 6527-6536, 2010.
7. Bruyère F, Hovens CM, Marson MN, et al: VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinoma. J Urol184: 1273-1278, 2010.
8. Hirata H, Hinoda Y, Nakajima K, et al: Wnt antagonist gene polymorphisms and renal cancer. Cancer115: 4488-4503, 2009.
9. Andreotti G, Boffetta P, Rosenberg PS, et al: Variants in blood pressure genes and the risk of renal cell carcinoma. Carcinogenesis31: 614-620, 2010.
10. Longuemaux S, Deloménie C, Gallou C, et al: Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res59: 2903-2908, 1999.
11. Aben KK, Luth TK, Janssen-Heijnen ML, Mulders PF, KiemeneyLA and van Spronsen DJ: No improvement in renal cell carcinoma survival: a population-based study in the Netherlands. Eur J Cancer44: 1701-1709, 2008.
12. Sun M, Shariat SF, Cheng C, et al: Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol60: 644-661, 2011.
13. Lughezzani G, Karakiewicz PI, Bigot P, et al: The prognostic value of erythrocyte polyamines in the preoperative evaluation of patients with renal cell carcinoma. Eur J Cancer 46: 1927-1935, 2010.
14. Doberstein K, Wieland A, Lee SB, et al: L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells. Carcinogenesis32: 262-270, 2011.
15. Kojima T, Shimazui T, Horie R, et al: FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma. Genes Chromosomes Cancer49: 379-389, 2010.
16. Li X, Tan X, Yu Y, et al: D9S168 microsatellite alteration predicts a poor prognosis in patients with clear cell renal cell carcinoma and correlates with the down-regulation of protein tyrosine phosphatase receptor delta. Cancer117: 4201-4211, 2011.
17. Kleinrath T, Gassner C, Lackner P, Thurnher M and RamonerR: Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma. J Clin Oncol25: 845-851, 2007.
18. Hirata H, Hinoda Y, Kikuno N, et al: MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma. Clin Cancer Res13: 4123-4129, 2007.
19. Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG and WuX: Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis31: 1805-1812, 2010.
20. Purdue MP, Johansson M, Zelenika D, et al: Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet43: 60-65, 2011.
21. Schödel J, Bardella C, Sciesielski LK, et al: Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclinD1 expression. Nat Genet44: 420-425, 2012.
22. Chang W, Ma L, Lin L, et al: Identification of novel hub genes associated with liver metastasis of gastric cancer. Int JCancer125: 2844-2853, 2009.
23. Wu X, Scelo G, Purdue MP, et al: A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Hum Mol Genet21: 456-462, 2012.
24. Han SS, Yeager M, Moore LE, et al: The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma. Hum Mol Genet21: 1190-1200, 2012.
25. Cao Q, Qin C, Ju X, et al: Chromosome 11q13.3 variant modifies renal cell cancer risk in a Chinese population. Mutagenesis27: 345-350, 2012.
26. Hedberg Y, Davoodi E, Roos G, Ljungberg B and LandbergG: Cyclin-D1 expression in human renal-cell carcinoma. Int JCancer84: 268-272, 1999.
27. Phuoc NB, Ehara H, Gotoh T, et al: Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma. Urology69: 843-848, 2007.
28. Allory Y, Matsuoka Y, Bazille C, Christensen EI, Ronco P and Debiec H: The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. Clin Cancer Res11: 1190-1197, 2005.
29. Migita T, Oda Y, Naito S and Tsuneyoshi M: Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma. Cancer94: 973-979, 2002.
30. Bilim V, Kawasaki T, Katagiri A, Wakatsuki S, Takahashi K and Tomita Y: Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations. Clin Cancer Res6: 460-466, 2000.